(Q33500299)

27 July 2017

title

Splenic irradiation in myeloid hemopathies: evaluation and toxicity (English)

1 reference

27 July 2017

author name string

Gonzague-Casabianca L

1

1 reference

27 July 2017

Bouabdallah R

2

1 reference

27 July 2017

Cowen D

3

1 reference

27 July 2017

Alzieu C

4

1 reference

27 July 2017

Richaud P

5

1 reference

27 July 2017

Resbeut M

6

1 reference

27 July 2017

publication date

1 January 1997

1 reference

27 July 2017

1 reference

27 July 2017

volume

1

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

213-221

1 reference

Single dose versus fractionated total body irradiation before bone marrow transplantation: radiobiological and clinical considerations.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989767-3

7 January 2021

Idiopathic myelofibrosis--an update with particular reference to clinical aspects and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989767-3

7 January 2021

Effect of Splenic Irradiation on Systemic Hematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989767-3

7 January 2021

Alpha-interferon in the treatment of idiopathic myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989767-3

7 January 2021

Splenic irradiation in myelofibrosis. Clinical findings and ferrokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989767-3

7 January 2021

Chronic granulocytic leukaemia: comparison of radiotherapy and busulphan therapy. Report of the Medical Research Council's working party for therapeutic trials in leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989767-3

7 January 2021

Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: is there a best choice? SFGM. Société Française de Greffe de Moelle.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989767-3

7 January 2021

Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. The Groupe d'Etude des greffes de moelle osseuse (GEGMO).

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989767-3

7 January 2021

Marrow transplantation for the treatment of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989767-3

7 January 2021

Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989767-3

7 January 2021

Idiopathic myelofibrosis: historical review, diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989767-3

7 January 2021

Splenic Irradiation Following Chemotherapy in Chronic Myelogenous Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989767-3

7 January 2021

10.1016/S1278-3218(97)89767-3

Identifiers

DOI

1 reference

27 July 2017

1 reference